Asthenia - 47 Studies Found
| Terminated |
: A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis : Myasthenia Gravis : 2012-03-13 : Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Participants will receive one dose of GM |
| Recruiting |
: Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis : Myasthenia Gravis, Generalized : 2015-06-23 :
|
| Completed |
: Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis : Myasthenia Gravis : 2006-03-21 : Drug: Intravenous ImmuneGlobulin |
| Recruiting |
: Exercise for Stable Myasthenia Gravis : Myasthenia Gravis : 2010-01-12 : Other: Exercise 3 month exercise intervention, three days |
| Active, not recruiting |
: Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis : Myasthenia Gravis : 2009-09-29 : Drug: Prednisone - Azathioprine Rapid strategy consists of |
| Recruiting |
: Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis : Myasthenia Gravis : 2014-01-13 : Behavioral: Physical exercise programme using a rowing machine 3 sessions per week of individualized phy |
| Completed |
: Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy : Myasthenia Gravis : 2006-02-21 :
|
| Completed |
: A Pilot Trial of Rituxan in Refractory Myasthenia Gravis : Refractory Myasthenia Gravis : 2008-01-14 : Drug: Rituximab (Rituxan) Four weekly IV infusions of Rituxan with dosage individually calculated per su |
| Active, not recruiting |
: Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis : Myasthenia Gravis : 2015-11-13 :
|
| Terminated |
: Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis : Myasthenia Gravis : 2011-11-01 : Drug: Subcutaneous immunoglobulins Immunoglobulins used subcutaneously for maintenance of other immune m |